BRIEF: YSB Inc.’s profit triples in first half of 2025
9885.HK
Pharmaceutical e-commerce platform YSB Inc. (9885.HK) announced on Thursday that it expects to record a net profit of 70 million yuan ($9.75 million) or more for the six months through June, more than triple the 21.8 million yuan it reported a year earlier.
The company credited the surge to steady revenue growth, strong demand for its high-margin self-branded products, and enhanced digital capabilities that improved the efficiency of its platform and direct-sales operations.
YSB‘s stock opened higher on Friday but later turn lower, closing at HK$10.02 by the midday break, down 2.34%. The stock is up 67.9% this year.
By Lee Shih Ta
To subscribe to Bamboo Works weekly free newsletter, click here
